Syntermed developed NeuroQ in affiliation with Daniel Silverman MD, PhD, Head of Neuronuclear Imaging Section of UCLA Medical Center.

NeuroQ has a validated capability to:

quantitatively detect clinically meaningful abnormalities of regional brain metabolism

accurately quantify the relative activity in multiple brain regions

Generate comprehensive color-coded image presentations

NeuroQ Processing Features

Capability to display both Hypometabolic and Hypermetabolic regions

Display of original, normal and refomatted brain transaxial slices

Ability to select the number of iterations for reformatted brain slices

Ability to interactively select the transaxial plane of the brain for display

Areas of non-significant (blue) intermediate (purple), and significant (red) hypometabolism are displayed with each transaxial slice

Choice of reference areas for internal normalizatoin (Pons, Cerebellum, Sensorimortor, Thalamus, or Whole Brain)

Provides quantitative output of regional data for abnormal areas in both visual and text formats

Click Here to Take a Closer Look at NeuroQ.  More.

How NeuroQ Works

 - NeuroQ performs automated analyses of brain PET scans, simultaneously quantifying activity in 240 standardized regions of interest

- The data are summarized and displayed in an easy-to-read, two-dimensional color-coded format, quantitatively comparing the activity in each region of the subject's brain to internal reference regions, and to the normalized activity values for those regions established for a group for asymptomatic control subjects.

- If there is abnormal cerebral metabolic function, NeuroQ shows you at a glace how abnormal, and how statistically important it is.